The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy

Sandrine M.G. Van De Pol; Patricia A.H. Doornaert; Remco De Bree; C. René Leemans; Ben J. Slotman; Johannes A. Langendijk

doi:https://doi.org/10.1016/j.oraloncology.2005.06.021

The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy

Sandrine M.G. Van De Pol, Patricia A.H. Doornaert, Remco De Bree, C. René Leemans, Ben J. Slotman, Johannes A. Langendijk

Research output: Contribution to journal › Article › Academic › peer-review

35 Citations (Scopus)

Abstract

The objective of this study was to investigate the prognostic significance of the hemoglobin (Hb) levels at different timepoints in locally advanced squamous cell carcinoma of the head and neck (SCCHN). Included were 111 patients. The hemoglobin levels were assessed before surgery (PreS-Hb), between surgery and radiotherapy (HbAAC), before postoperative radiotherapy (PreRT-Hb) and at the end of radiotherapy (EndRT-Hb). HbAAC takes into account the duration of anemia during the interval between surgery and radiotherapy. Higher HbAAC corresponds with lower Hb levels. Five year locoregional control (LRC) among patients with HbAAC ≥ median was 72% and significantly worse as compared to the 88% in case of HbAAC < median (p = 0.0097). Multivariate analysis for LRC showed that the HbAAC was a prognostic factor. Overall survival (OS) after 3 years was 77% in case of HbAAC < median and 34% in case of HbAAC ≥ median (p < 0.0002). Multivariate analysis for OS showed that the PreS-Hb and HbAAC were prognostic factors. Hb level between surgery and radiotherapy is an important prognostic factor for both LRC and OS among patients with SCCHN treated with surgery and postoperative radiotherapy.

Original language	English
Pages (from-to)	131-138
Number of pages	8
Journal	Oral Oncology
Volume	42
Issue number	2
DOIs	https://doi.org/10.1016/j.oraloncology.2005.06.021
Publication status	Published - Feb 2006

Keywords

Anemia
Head and neck cancer
Hemoglobin
Postoperative radiotherapy
Prognostic factors

Access to Document

https://doi.org/10.1016/j.oraloncology.2005.06.021

Cite this

@article{a3fbb0036a674da8981b37b3b6664542,

title = "The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy",

abstract = "The objective of this study was to investigate the prognostic significance of the hemoglobin (Hb) levels at different timepoints in locally advanced squamous cell carcinoma of the head and neck (SCCHN). Included were 111 patients. The hemoglobin levels were assessed before surgery (PreS-Hb), between surgery and radiotherapy (HbAAC), before postoperative radiotherapy (PreRT-Hb) and at the end of radiotherapy (EndRT-Hb). HbAAC takes into account the duration of anemia during the interval between surgery and radiotherapy. Higher HbAAC corresponds with lower Hb levels. Five year locoregional control (LRC) among patients with HbAAC ≥ median was 72% and significantly worse as compared to the 88% in case of HbAAC < median (p = 0.0097). Multivariate analysis for LRC showed that the HbAAC was a prognostic factor. Overall survival (OS) after 3 years was 77% in case of HbAAC < median and 34% in case of HbAAC ≥ median (p < 0.0002). Multivariate analysis for OS showed that the PreS-Hb and HbAAC were prognostic factors. Hb level between surgery and radiotherapy is an important prognostic factor for both LRC and OS among patients with SCCHN treated with surgery and postoperative radiotherapy.",

keywords = "Anemia, Head and neck cancer, Hemoglobin, Postoperative radiotherapy, Prognostic factors",

author = "{Van De Pol}, {Sandrine M.G.} and Doornaert, {Patricia A.H.} and {De Bree}, Remco and Leemans, {C. Ren{\'e}} and Slotman, {Ben J.} and Langendijk, {Johannes A.}",

year = "2006",

month = feb,

doi = "https://doi.org/10.1016/j.oraloncology.2005.06.021",

language = "English",

volume = "42",

pages = "131--138",

journal = "Oral Oncology",

issn = "1368-8375",

publisher = "Elsevier Limited",

number = "2",

}

TY - JOUR

T1 - The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy

AU - Van De Pol, Sandrine M.G.

AU - Doornaert, Patricia A.H.

AU - De Bree, Remco

AU - Leemans, C. René

AU - Slotman, Ben J.

AU - Langendijk, Johannes A.

PY - 2006/2

Y1 - 2006/2

N2 - The objective of this study was to investigate the prognostic significance of the hemoglobin (Hb) levels at different timepoints in locally advanced squamous cell carcinoma of the head and neck (SCCHN). Included were 111 patients. The hemoglobin levels were assessed before surgery (PreS-Hb), between surgery and radiotherapy (HbAAC), before postoperative radiotherapy (PreRT-Hb) and at the end of radiotherapy (EndRT-Hb). HbAAC takes into account the duration of anemia during the interval between surgery and radiotherapy. Higher HbAAC corresponds with lower Hb levels. Five year locoregional control (LRC) among patients with HbAAC ≥ median was 72% and significantly worse as compared to the 88% in case of HbAAC < median (p = 0.0097). Multivariate analysis for LRC showed that the HbAAC was a prognostic factor. Overall survival (OS) after 3 years was 77% in case of HbAAC < median and 34% in case of HbAAC ≥ median (p < 0.0002). Multivariate analysis for OS showed that the PreS-Hb and HbAAC were prognostic factors. Hb level between surgery and radiotherapy is an important prognostic factor for both LRC and OS among patients with SCCHN treated with surgery and postoperative radiotherapy.

AB - The objective of this study was to investigate the prognostic significance of the hemoglobin (Hb) levels at different timepoints in locally advanced squamous cell carcinoma of the head and neck (SCCHN). Included were 111 patients. The hemoglobin levels were assessed before surgery (PreS-Hb), between surgery and radiotherapy (HbAAC), before postoperative radiotherapy (PreRT-Hb) and at the end of radiotherapy (EndRT-Hb). HbAAC takes into account the duration of anemia during the interval between surgery and radiotherapy. Higher HbAAC corresponds with lower Hb levels. Five year locoregional control (LRC) among patients with HbAAC ≥ median was 72% and significantly worse as compared to the 88% in case of HbAAC < median (p = 0.0097). Multivariate analysis for LRC showed that the HbAAC was a prognostic factor. Overall survival (OS) after 3 years was 77% in case of HbAAC < median and 34% in case of HbAAC ≥ median (p < 0.0002). Multivariate analysis for OS showed that the PreS-Hb and HbAAC were prognostic factors. Hb level between surgery and radiotherapy is an important prognostic factor for both LRC and OS among patients with SCCHN treated with surgery and postoperative radiotherapy.

KW - Anemia

KW - Head and neck cancer

KW - Hemoglobin

KW - Postoperative radiotherapy

KW - Prognostic factors

UR - http://www.scopus.com/inward/record.url?scp=30844469074&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/j.oraloncology.2005.06.021

DO - https://doi.org/10.1016/j.oraloncology.2005.06.021

M3 - Article

C2 - 16146705

SN - 1368-8375

VL - 42

SP - 131

EP - 138

JO - Oral Oncology

JF - Oral Oncology

IS - 2

ER -

The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy

Abstract

Keywords

Access to Document

Other files and links

Cite this